Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Minireviews
    • JVI Classic Spotlights
    • Archive
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JVI
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Journal of Virology
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Minireviews
    • JVI Classic Spotlights
    • Archive
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JVI
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Virus-Cell Interactions

Localization of Human Cytomegalovirus Structural Proteins to the Nuclear Matrix of Infected Human Fibroblasts

V. Sanchez, P. C. Angeletti, J. A. Engler, W. J. Britt
V. Sanchez
Departments of Microbiology,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
P. C. Angeletti
Biochemistry and Molecular Genetics, and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J. A. Engler
Biochemistry and Molecular Genetics, and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
W. J. Britt
Departments of Microbiology,
Pediatrics, University of Alabama at Birmingham, Birmingham, Alabama 35233
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/JVI.72.4.3321-3329.1998
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Fig. 1.
    • Open in new tab
    • Download powerpoint
    Fig. 1.

    HCMV pp65 is a nuclear protein that is detected in subnuclear structures. HF were grown on coverslips and infected with AD169. Three to five days postinfection (100% cytopathic effect), cells were fixed and stained in immunofluorescence assays with the pp65-specific MAb 65-8 (A), MAb 28-19 (B), or polyclonal guinea pig serum against bacterially expressed pp65 (C). Cos7 cells transfected with a vector expressing pp65 (D) or an EGFP-pp65 fusion protein (E and F) were fixed and stained with MAb 28-19 (D only). Magnifications: (A to C) ×400; (D to F) ×1,000.

  • Fig. 2.
    • Open in new tab
    • Download powerpoint
    Fig. 2.

    HCMV-encoded structural and nonstructural proteins are retained in the nuclear matrix of HCMV AD169-infected human fibroblasts. Nuclei from AD169-infected HF were isolated by treatment with nonionic detergent and then treated with DNase and high salt to remove soluble components from the nuclear matrix fraction. (A) Nuclear matrix-containing filters were probed with MAbs specific for gB, IE1, IE2, ppUL44, ppUL69, pp28, MCP, and pp65. (B) Filters containing proteins from nuclear matrix fractions washed with 1 M guanidine hydrochloride prior to electrophoretic separation were probed with the antibodies listed above. Sizes are indicated in kilodaltons.

  • Fig. 3.
    • Open in new tab
    • Download powerpoint
    Fig. 3.

    Quantitative Western blots of nuclear matrix preparations from AD169-infected HF. HCMV-infected cells were fractionated, and protein content in each fraction was determined as described in Materials and Methods. Twenty-five micrograms of each of the fractions was loaded into the lanes (C, cytoplasm, soluble protein; N, detergent-treated nuclei; NM, nuclear matrix pellet; GW, guanidine hydrochloride-washed NM) and transferred to nitrocellulose filters. Filters were reacted with MAb p63-27 against IE-1 (A) or MAb 28-19 against pp65 (B) and processed for autoradiography. Counts for each fraction were determined on a PhosphorImager and were as follows: IE-1, 449,874.4, 13,951.6, 9,332.5, and 9,514.3 for C, N, NM, and GW fractions, respectively; pp65 (68 kDa), 239,720.7, 2,048,547.0, 1,206,468.7, and 1,172,115.9 for C, N, NM, and GW fractions, respectively; pp65 (50-kDa form), 33,155.2, 1,003,560.2, 774,609.0, and 188,991.4 for C, N, NM, and GW fractions, respectively. Sizes are indicated in kilodaltons.

  • Fig. 4.
    • Open in new tab
    • Download powerpoint
    Fig. 4.

    Immunofluorescence assays of in situ-extracted, AD169-infected HF. HF grown on glass coverslips were infected with HCMV AD169 5 days prior to harvesting. Infected cells were untreated (A, C, E, G, and I) or extracted with detergent, DNase, and high salt (B, D, F, H, and J) before fixation with 2.5% paraformaldehyde. Coverslips were then reacted with MAbs specific for IE-1 (A and B), ppUL44 (C and D), MCP (E and F), ppUL69 (G and H), or pp65 (I and J). Antibody binding was detected with FITC-conjugated goat anti-mouse IgG antibody and recorded by conventional fluorescence microscopy. Magnification for all frames is ×348.

  • Fig. 5.
    • Open in new tab
    • Download powerpoint
    Fig. 5.

    pp65 expressed by recombinant vaccinia virus vv-pp65 is retained in the nuclear matrix of infected BSC-1 monkey cells. Cytoplasmic (C), nuclear (N), nuclear matrix (NM), and guanidine-washed nuclear matrix (GW) fractions were prepared from recombinant vaccinia virus vv-Eco V gb (A)- or vv-pp65 (B)-infected BSC-1 cells as described in Materials and Methods. The samples (10 μg per lane) were analyzed by Western blotting using a gB-specific or pp65-specific MAb and developed with 125I-protein A. Sizes are indicated in kilodaltons.

  • Fig. 6.
    • Open in new tab
    • Download powerpoint
    Fig. 6.

    pp65 binds to a nuclear matrix protein which comigrates with lamin B1 in vitro. (A) Nuclear matrix material was isolated from the human carcinoma cell line HEp-2 as described in Materials and Methods. Proteins were electrophoretically separated and then blotted onto nitrocellulose. Filters were then reacted with pp65-specific MAb 28-19 (lane C), purified pp65 followed by anti-pp65 MAb 28-19 (lane FW), or anti-lamin B1 MAb NA12 (lane NA12). Antibody binding was detected by addition of anti-mouse IgG antibody followed by125I-protein A and autoradiography. Migration of molecular mass markers is shown in kilodaltons at the left. (B) Coprecipitation of pp65 and lamins from soluble nuclear matrix extracts. Soluble nuclear matrix extracts prepared from AD169-infected HF were immunoprecipitated with MAbs against pp65. Immunoprecipitated proteins were separated by SDS-PAGE and transferred to nitrocellulose for Western blotting with antibodies specific for pp65 (28-19), lamins (237), and a control MAb specific for ppUL44 (28-21). Antibody binding was detected by addition of rabbit anti-mouse IgG antibody (lanes 28-19 and 28-21 only) followed by 125I-protein A and autoradiography. Immunoglobulin heavy chains were detected with a rabbit anti-mouse immunoglobulin antibody followed by addition of125I-protein A and autoradiography (lane C). Migration of the molecular mass marker (in kilodaltons) and immunoglobulin heavy chains (Hc) is shown in the margins.

  • Fig. 7.
    • Open in new tab
    • Download powerpoint
    Fig. 7.

    Colocalization of pp65 and lamins. Nuclear matrix-extracted (A to C) or unextracted (D to F) HCMV-infected cells were stained with a murine MAb against pp65 (green; A and D) and a rabbit antiserum against lamins a and c (red; B) or against lamin b (red; E). Colocalization (blue) of pp65 and lamins is shown in panels C and F. Magnification for all panels, ×890.

Tables

  • Figures
  • Table 1.

    Enrichment of pp65 on the nuclear matrix

    Fractiona% Total cellular proteinb% of protein in fractionc
    IE-1pp65 (68 kDa)pp65 (50 kDa)
    Cytoplasm/soluble protein86.393.2 (1.08d)5.1 (0.06)1.7 (0.02)
    Detergent-treated nuclei8.92.9 (0.33)43.9 (4.93)50.2 (5.64)
    Nuclear matrix3.01.9 (0.63)25.9 (8.63)38.7 (12.94)
    Guanidine-HCl-washed nuclear matrix1.82.0 (1.11)25.1 (13.94)9.4 (5.22)
    • ↵a HCMV-infected HF were fractionated into the indicated cellular fractions as described in Materials and Methods.

    • ↵b The amount of total protein represented in each fraction was determined as described in Materials and Methods, and the percentage of total cellular protein was calculated as follows: % = (total protein in fraction/total cellular protein) × 100.

    • ↵c The amount of IE-1, pp65 (68 kDa) or pp65 (50 kDa) in each fraction was determined by phosphorimaging. The results are presented as the percentage of total IE-1, pp65 (68 kDa), or pp65 (50 kDa) in each fraction as calculated by the following formula: % = (counts in fraction/total counts for protein) × 100.

    • ↵d The specific enrichment of each protein in a specific fraction, determined by the following formula: enrichment = % of protein determined in footnote c/% of total cellular protein determined in footnote b.

PreviousNext
Back to top
Download PDF
Citation Tools
Localization of Human Cytomegalovirus Structural Proteins to the Nuclear Matrix of Infected Human Fibroblasts
V. Sanchez, P. C. Angeletti, J. A. Engler, W. J. Britt
Journal of Virology Apr 1998, 72 (4) 3321-3329; DOI: 10.1128/JVI.72.4.3321-3329.1998

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Journal of Virology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Localization of Human Cytomegalovirus Structural Proteins to the Nuclear Matrix of Infected Human Fibroblasts
(Your Name) has forwarded a page to you from Journal of Virology
(Your Name) thought you would be interested in this article in Journal of Virology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Localization of Human Cytomegalovirus Structural Proteins to the Nuclear Matrix of Infected Human Fibroblasts
V. Sanchez, P. C. Angeletti, J. A. Engler, W. J. Britt
Journal of Virology Apr 1998, 72 (4) 3321-3329; DOI: 10.1128/JVI.72.4.3321-3329.1998
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

cytomegalovirus
Fibroblasts
Nuclear Matrix
Phosphoproteins
Viral Matrix Proteins
viral structural proteins

Related Articles

Cited By...

About

  • About JVI
  • Editor in Chief
  • Editorial Board
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Ethics
  • Contact Us

Follow #Jvirology

@ASMicrobiology

       

 

JVI in collaboration with

American Society for Virology

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0022-538X; Online ISSN: 1098-5514